17周年大视野精选

What BioNTech did next: the plan for a revolution in cancer care
BioNTech能为癌症治疗带来一场革命吗?

The German company is ploughing Covid vaccine profits into oncology but its technology is still largely unproven
这家德国公司正将新冠疫苗的利润投入肿瘤学领域,但其技术在很大程度上仍未得到验证。

Uğur Şahin arrives at BioNTech’s headquarters in the German city of Mainz on the same battered bicycle he has been riding for 20 years. Developing the best-selling Covid-19 vaccine may have transformed BioNTech’s founders into billionaires, but the chief executive of the biotech business has resisted making changes in his personal life.

乌尔·沙欣(Uğur Şahin)骑着他已经20岁高龄的破旧自行车来到位于德国美因茨市的BioNTech总部。开发最畅销的新冠疫苗可能使BioNTech的创始人变成了亿万富翁,但这家生物技术企业的首席执行官却抵制在个人生活中作出改变。

您已阅读2%(455字),剩余98%(19210字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×